​

Biodesix (BDSX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BDSX Stock Forecast

Biodesix (BDSX) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $28.33, with a high of $32.00 and a low of $26.00. This represents a 41.93% increase from the last price of $19.96.

- $7 $14 $21 $28 $35 High: $32 Avg: $28.33 Low: $26 Last Closed Price: $19.96

BDSX Stock Rating

Biodesix stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (85.71%), 1 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 6 Strong Sell Sell Hold Buy Strong Buy

BDSX Price Target Upside V Benchmarks

TypeNameUpside
StockBiodesix41.93%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks7.54%

Price Target Trends

1M3M12M
# Anlaysts234
Avg Price Target$29.50$28.33$26.25
Last Closing Price$19.96$19.96$19.96
Upside/Downside47.80%41.93%31.51%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 26-7---7
Jun, 26-5---5
May, 26-5---5
Apr, 26-5---5
Mar, 26-5---5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 24, 2026Max MasucciRoth Capital$32.00$18.6771.40%60.32%
Jun 18, 2026Kyle MiksonCanaccord Genuity$27.00$15.2277.40%35.27%
Jun 15, 2026H.C. Wainwright$26.00$15.0672.64%30.26%
Sep 19, 2025Canaccord Genuity$20.00$6.69198.95%0.20%
Sep 16, 2024Sung Ji NamScotiabank$3.00$1.8264.84%-84.97%
Jul 26, 2024Bill BonelloCraig-Hallum$3.00$1.6878.57%-84.97%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 24, 2026Roth CapitalBuyinitialise
Jun 15, 2026H.C. WainwrightBuyinitialise
Feb 27, 2026William BlairMarket PerformOutperformupgrade
May 14, 2025Lake StreetBuyBuyhold
May 14, 2025William BlairMarket Performdowngrade
Sep 16, 2024ScotiabankOutperforminitialise
Jul 26, 2024Craig-HallumBuyinitialise
May 13, 2024Cowen & Co.Buyinitialise

Financial Forecast

EPS Forecast

$-35 $-28 $-21 $-14 $-7 $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-31.60$-31.00$-12.80$-6.60$-4.67---
Avg Forecast$-1.58$-1.44$-0.66$-0.35$-0.22$-0.15$-0.08$-0.01
High Forecast$-1.54$-1.40$-0.64$-0.34$-0.21$-0.12$-0.07$-0.01
Low Forecast$-1.62$-1.50$-0.68$-0.37$-0.23$-0.18$-0.08$-0.01
Surprise %1900.00%2052.78%1839.39%1785.71%2022.73%---

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$54.51M$38.21M$49.09M$71.32M$88.50M---
Avg Forecast$54.68M$39.31M$50.14M$70.78M$93.11M$115.37M$130.00M$155.70M
High Forecast$55.93M$40.45M$50.31M$73.33M$94.49M$116.16M$132.35M$161.32M
Low Forecast$53.79M$38.45M$49.97M$68.96M$91.73M$114.58M$127.65M$151.69M
Surprise %-0.33%-2.79%-2.09%0.77%-4.95%---

Net Income Forecast

$-150M $-120M $-90M $-60M $-30M $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-43.16M$-65.45M$-52.15M$-42.93M$-35.27M---
Avg Forecast$-129.50M$-118.64M$-53.84M$-28.84M$-17.91M$-12.59M$-6.20M$-821.13K
High Forecast$-126.75M$-115.27M$-52.19M$-27.69M$-17.20M$-10.07M$-5.95M$-793.63K
Low Forecast$-133.34M$-123.12M$-55.50M$-29.99M$-18.63M$-15.11M$-6.45M$-859.64K
Surprise %-66.67%-44.84%-3.15%48.85%96.87%---

BDSX Forecast FAQ

Is Biodesix stock a buy?

Biodesix stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Biodesix is a favorable investment for most analysts.

What is Biodesix's price target?

Biodesix's price target, set by 7 Wall Street analysts, averages $28.33 over the next 12 months. The price target range spans from $26 at the low end to $32 at the high end, suggesting a potential 41.93% change from the previous closing price of $19.96.

How does Biodesix stock forecast compare to its benchmarks?

Biodesix's stock forecast shows a 41.93% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the diagnostics & research stocks industry (7.54%).

What is the breakdown of analyst ratings for Biodesix over the past three months?

  • July 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Biodesix’s EPS forecast?

Biodesix's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.15, marking a -96.79% decrease from the reported $-4.67 in 2025. Estimates for the following years are $-0.08 in 2027, and $-0.01 in 2028.

What is Biodesix’s revenue forecast?

Biodesix's average annual revenue forecast for its fiscal year ending in December 2026 is $115.37M, reflecting a 30.36% increase from the reported $88.5M in 2025. The forecast for 2027 is $130M, and $155.7M for 2028.

What is Biodesix’s net income forecast?

Biodesix's net income forecast for the fiscal year ending in December 2026 stands at $-12.59M, representing a -64.30% decrease from the reported $-35.265M in 2025. Projections indicate $-6.2M in 2027, and $-821K in 2028.